Serum KL-6 levels were associated with the baseline characteristics of lung cancer, including comorbidity (underlying ILD), ECOG PS score, histology, stage (advanced), baseline lung function (FVC, DLCO), and a tumor marker (CEA). The gene discussed is CEACAM5; the disease is lung carcinoma.